Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer

NCT03565536 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Fujian Medical University